The Asus VivoWatch 6 Aero should let you stick your finger on the watch face to get a blood oxygen and blood pressure reading.

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings ...

Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

Dexcom has won a clearance from the FDA for its longest-lasting continuous glucose monitor, a 15-day version of its flagship ...

Wearable health technology enhances preventive care, enabling continuous monitoring of vital signs and proactive disease management for better health outcomes.

Biosensors market in 2025 is driven by advanced healthcare applications, dominated by oxidoreductase enzymes and non-wearable ...

The US Food and Drug Administration has cleared the Dexcom G7 15-Day Continuous Glucose Monitor (CGM) for people older than 18 with diabetes. It's the longest-lasting wearable on the market.